Novel Neurodegenerative Biomarkers for Precision Diagnostics and Clinical Trials

11:00 am - Tuesday 3rd February 2026

  • High Resolution Mass Spectrometry Assays
  • Non-invasive, affordable, scalable, and robustly clinically validated tests
  • PrecivityAD2™ Test: An Advanced Blood Test for Brain Amyloid Detection
  • eMTBR-tau243 – tangle specific novel biomarker for tau pathology Robust biomarkers for pharmacodynamic monitoring in clinical trails

Speakers:

Senior Director - Project Management
C2N Diagnostics LLC